![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Padrik Peeter
Publisher: Humana Press, Inc
ISSN: 1357-0560
Source: Medical Oncology, Vol.20, Iss.4, 2003-12, pp. : 325-334
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By de Wit R. Pawinsky A. Stoter G. van Oosterom A.T. Fossa S.D. Paridaens R. Svedberg A. de Mulder P.H.M.
European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Donskov Frede Bennedsgaard Karen Hokland Marianne Marcussen Niels Fisker Rune Madsen Hans Fode Kirsten Maase Hans
Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sunitinib for metastatic renal cell carcinoma
By Mukherji Deborah Larkin James Pickering Lisa
Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Ramoner Reinhold Rahm Andrea Gander Hubert Stollenwerk Björn Falkensammer Claudia Leonhartsberger Nicolai Thurnher Martin
Cancer Immunology, Immunotherapy, Vol. 57, Iss. 8, 2008-08 ,pp. :